View in EDS PDF Full Text

LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer.

Saved in:
Bibliographic Details
Title: LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer.
Authors: Zarka, Jabra1,2 (AUTHOR) zarka.jabra@mayo.edu, Juthani, Ronit3 (AUTHOR), Sartor, Oliver4 (AUTHOR), Muniz, Miguel1 (AUTHOR), Kase, Adam M.5 (AUTHOR), Riaz, Irbaz B.6 (AUTHOR), Naqvi, Arsalan6 (AUTHOR), Heath, Elisabeth1 (AUTHOR), Orme, Jacob J.1 (AUTHOR), Scharf, Zachary1 (AUTHOR), Belge Bilgin, Gokce7 (AUTHOR), Kwon, Eugene D.8 (AUTHOR), Jang, Albert1 (AUTHOR), Tarhini, Ali1 (AUTHOR), Johnson, Geoffrey B.7 (AUTHOR), Kendi, Ayse Tuba7 (AUTHOR), Thorpe, Matthew P.7 (AUTHOR), Patnaik, Mrinal S.2 (AUTHOR), Kusne, Yael2 (AUTHOR), Jacene, Heather9 (AUTHOR)
Source: Clinical Genitourinary Cancer. Jun2026, Vol. 24 Issue 4, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:15587673
DOI:10.1016/j.clgc.2026.102552